期刊文献+

尿毒症肌少症的发病机制和治疗 被引量:31

The pathogenesis and treatment of uraemic sarcopenia
暂未订购
导出
摘要 肌少症是以骨骼肌质量、力量以及功能降低为主要特征的退行性综合征。年龄与肌少症密切相关,然而,慢性肾脏病尤其终末期肾病可加速肌肉消耗,增加肌少症发生率。导致尿毒症肌少症因素较多,如激素、免疫和肌细胞的改变,代谢性酸中毒,蛋白质摄入减少及运动减少等。尿毒症合并肌少症发生率高,且死亡率高,因而,需要早期预防、早期诊断和治疗。 Sarcopenia is a syndrome characterized by progressive and generalized loss of skeletal muscle mass and strength. Ageing is associated with sarcopenia, and end-stage renal disease accelerates the normal physiological muscle wasting resulting in an increasing prevalence of sarcopenia, which is named uraemic sarcopenia. There are several mechanisms that may be involved in the onset and progression of uraemic sarcopenia, such as hormones, changes in immune and muscle cells, metabolic acidosis, reducing protein intake and so on. Uraemic sarcopenia presents a high probability for morbidity and mortality, and consequently a high priority for muscle wasting prevention and treatment in these patients.
出处 《肾脏病与透析肾移植杂志》 CSCD 北大核心 2015年第2期181-185,共5页 Chinese Journal of Nephrology,Dialysis & Transplantation
基金 国家科技支撑计划项目(2013BAI09B04)(2015BAI12B05) 江苏省临床医学中心项目(BL2012007)
关键词 尿毒症 肌少症 发病机制 uraemic sarcopenia pathogenesis
  • 相关文献

参考文献26

  • 1A Sayer A, Stewart C, Patel H, et al. The developmental origins of sarcopenia: from epidemiological evidence to underlying mechanisms. J Dev Orig Health Dis,2010,1 (3) :150-157.
  • 2Janssen I, Shepard DS, Katzmarzyk PT, et al. The healthcare costs of sarcopenia in the United States. J Am Geriatr Soc, 2004, 52 ( 1 ) : 80-85.
  • 3Domaflski M ,Ciechanowski K.Sarcopenia: a major challenge in elderly patients with end-stage renal diseasc.J Aging Res ,2012,2012:754739.
  • 4Greeo A, Paroni G, Seripa D, et al. Frailty, disability and physical exercise in the aging process and in chronic kidney disease. Kidney Blood Press Res, 2014,39 (2-3) : 164-168.
  • 5Kim JC, Kalantar-Zadeh K, Kopple JD. Frailty and protein-energy wasting in elderly patients with end stage kidney disease. J Am Soc Nephrol,2013,24(3) : 337-351.
  • 6Lamarea F, Carrero JJ, Rodrigues JC, et al.Prevalence of sarcopenia in elderly maintenance hemodialysis patients: the impact of different diagnostic criteria.J Nutr Health Aging, 2014,18 (7) : 710-717.
  • 7Cruz-Jentoft AJ, Baeyens JP, Bauer JM, et al. Sarcopenia: European consensus on definition and diagnosis: Report of the European Working Group on Sarcopenia in Older People. Age Ageing, 2010,39 (4) :412-423.
  • 8Kim JK,Choi SR,Choi MJ,et al.Prevalence of and factors associated with sarcopenia in elderly patients with end-stage renal disease. Clin Nutr, 2014,33 ( 1 ) : 64-68.
  • 9Fahal IH.Uraemic sarcopenia:aetiology and implications.Nephrol Dial Transplant, 2014,29 (9) : 1655-1665.
  • 10Mak RH, Ikizler AT, Kovesdy CP, et al. Wasting in chronic kidney disease.J Cachexia Sarcopenia Muscle, 2011,2 ( 1 ) : 9-25.

同被引文献150

引证文献31

二级引证文献299

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部